Cost effectiveness of screening and statin therapy in clinical guidelines for cardiovascular prophylaxis

被引：0
|
作者：
Milne, RJ [1 ]
Gamble, GD [1 ]
机构：
[1] Univ Auckland, Auckland 1, New Zealand
来源：
VALUE IN HEALTH | 2004年 / 7卷 / 03期
关键词：
D O I：
10.1016/S1098-3015(10)62091-8
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：228 / 228
页数：1
相关论文
共 50 条
  • [1] Determinants of cost effectiveness in clinical guidelines for cardiovascular prophylaxis with statins
    Milne, RJ
    Gamble, GD
    VALUE IN HEALTH, 2003, 6 (03) : 319 - 319
  • [2] Cost-effectiveness of Statin Use Guidelines
    Blum, Conrad B.
    Stone, Neil J.
    JAMA CARDIOLOGY, 2021, 6 (03) : 363 - 364
  • [3] The cost-effectiveness of icosapent ethyl in combination with statin therapy compared with statin alone for cardiovascular risk reduction
    Ademi, Zanfina
    Ofori-Asenso, Richard
    Zomer, Ella
    Owen, Alice
    Liew, Danny
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2021, 28 (08) : 897 - 904
  • [4] Cost-effectiveness of C-reactive protein screening to target statin therapy
    Blake, GJ
    Ridker, PM
    Kuntz, KM
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (05) : 440A - 440A
  • [5] COST EFFECTIVENESS OF STATIN THERAPY IN SOUTH KOREA
    Bae, E. Y.
    Bae, S.
    Lim, M. K.
    Choi, S. E.
    VALUE IN HEALTH, 2009, 12 (07) : A333 - A333
  • [6] Cost Effectiveness of Nonstatin-to-Statin Therapy
    Koh, Kwang Kon
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (15) : 1995 - 1995
  • [7] Cost-effectiveness of statin therapy in The Netherlands
    Goes, ES
    VanHout, BA
    AMERICAN JOURNAL OF MANAGED CARE, 1997, 3 (10): : LC3 - LC3
  • [8] Noncompliance with statin therapy: Lost clinical benefits and implications for cost-effectiveness.
    Benner, JS
    Ganz, DA
    Weinstein, MC
    Neumann, PJ
    Glynn, RJ
    Avorn, J
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2002, 17 : 135 - 135
  • [9] Cost-effectiveness of Statin Use Guidelines-Reply
    Pandya, Ankur
    Zhu, Jinyi
    Spahillari, Aferdita
    JAMA CARDIOLOGY, 2021, 6 (03) : 364 - 364
  • [10] Hepatitis B, Rituximab, Screening, and Prophylaxis: Effectiveness and Cost Effectiveness
    Hay, Annette E.
    Meyer, Ralph M.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (26) : 3155 - 3157
12345